Company Overview of Apothogen, Inc.
Apothogen Inc has merged with IntraBiotics. Apothogen Inc. was formed as a result of a joint venture between JP Morgan Partners and PPD Inc. in October 2001. Apothogen Inc. acquires, develops, and commercializes pharmaceutical products. It is based in Wilmington, North Carolina. Apothogen, Inc. was formerly a subsidiary of IntraBiotics Pharmaceuticals, Inc. Apothogen, Inc. is a subsidiary of Ardea Biosciences, Inc.
Wilmington, NC 28411
Founded in 2001
Key Executives for Apothogen, Inc.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Apothogen, Inc., please visit www.apothogen.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.